Immune checkpoint inhibitor using in cases with gestational trophoblastic diseases Semra Paydas Review Article 23 February 2023 Article: 106
Design of a potential Sema4A-based multi-epitope vaccine to combat triple-negative breast cancer: an immunoinformatic approach Priyanga ParanthamanShanthi Veerappapillai Original Paper 23 February 2023 Article: 105
Erythrose inhibits the progression to invasiveness and reverts drug resistance of cancer stem cells of glioblastoma Juan Carlos Gallardo-PérezMaría Cristina Trejo-SolísLaura Gabriela Sánchez-Lozada Original Paper 23 February 2023 Article: 104
The in vitro treatment of mesenchymal stem cells for colorectal cancer cells Figen Abatay-SelAyse ErolFatma Savran-Oguz Original Paper 22 February 2023 Article: 103
MORC2 and MAX contributes to the expression of glycolytic enzymes, breast cancer cell proliferation and migration Rohith Kumar GuddetiHimavani PacharlaSuresh B. Pakala Original Paper 21 February 2023 Article: 102
Relationship between glioblastoma multiforme (GBM) and Alzheimer’s disease (AD): is there any reporting bias? Mobin Ibne MokbulAbu Bakar Siddik Letter to the Editor 21 February 2023 Article: 101
Identification of potential tumor antigens and immune subtypes for lung adenocarcinoma Maoshu BaiXin LiuLingling Wang Original Paper 21 February 2023 Article: 100
Neolamarckia cadamba (Roxb.) Bosser (Rubiaceae) extracts: promising prospects for anticancer and antibacterial potential through in vitro and in silico studies Anamika MishraSantosh Kumar MauryaNidhi Mishra Original Paper 20 February 2023 Article: 99
Propionate-producing Veillonella parvula regulates the malignant properties of tumor cells of OSCC Xinxia ChangYufeng ChenGenxiong Tang Original Paper 19 February 2023 Article: 98
Function of TRPC1 in modulating hepatocellular carcinoma progression Huimin QiFengming WuHongmei Wang Original Paper 16 February 2023 Article: 97
Upregulation of TUBG1 expression promotes hepatocellular carcinoma development Zi-jian WangZhi-zheng DaiKai-Fu Tang Original Paper 15 February 2023 Article: 96
The past, present, and future of immunotherapy for colorectal cancer Cole R. FormslagLei ZhaoYujiang Fang Review Article 14 February 2023 Article: 95
NLRP3 inflammasome activation By 17β-estradiol is a potential therapeutic target in hepatocellular carcinoma treatment Sara F. AwwadRaymonde H. AssafAya A. El-Hanafy Original Paper Open access 10 February 2023 Article: 94
Epidemiological trends and risk factors of gynecological cancers: an update Vahideh KeyvaniNahid KheradmandSeyed-Alireza Esmaeili Review Article 09 February 2023 Article: 93
Clinical application of liquid biopsy in endometrial carcinoma Yan ShenRui ShiHongbo Wang Review Article Open access 09 February 2023 Article: 92
Photodynamic therapy in oral cancer: a review of clinical studies Seyed Ali MosaddadReza Abdollahi NamanlooHamid Tebyaniyan Review Article 07 February 2023 Article: 91
CAFs secrete CXCL12 to accelerate the progression and cisplatin resistance of colorectal cancer through promoting M2 polarization of macrophages Hang JiangHaijue GeHongqin Yue Original Paper 03 February 2023 Article: 90
RUNX3 improves CAR-T cell phenotype and reduces cytokine release while maintaining CAR-T function Xiuxiu ZhuWuling LiCheng Qian Original Paper 03 February 2023 Article: 89
Chemotherapy: how to reduce its adverse effects while maintaining the potency? BriannaSau Har Lee Review Article 03 February 2023 Article: 88
Niosomes nanoparticles as a novel approach in drug delivery enhances anticancer properties of chrysin in human ovarian carcinoma cells (SKOV3): an in vitro study Mahdieh TarahomiAkram Firouzi AmandiBahman Yousefi Original Paper 01 February 2023 Article: 87
Wnt3a is a promising target in colorectal cancer Muhammad TufailChangxin Wu Review Article 31 January 2023 Article: 86
B7-H6 enhances F-actin rearrangement by targeting c-MYC activation to promote medulloblastoma migration and invasion Jianing FanYangyang WangYu Li Original Paper 24 January 2023 Article: 85
